Cancer Research
3 stories
-
healthUltra-Refractory Myeloma: Genomic Complexity and Dire Outcomes
New data reveals extreme genomic complexity in hepta-refractory multiple myeloma, with limited survival and urgent need for novel therapies.
-
healthHead and Neck Cancer: Immunotherapy and Oncolytic Viruses Reshape Treatment
Explore the cutting edge of head and neck cancer treatment, focusing on immunotherapy and oncolytic viruses, with insights from leading oncologist Kevin Harrington.
-
healthR-CHOP Retreatment Shows Promise for Late Relapse Lymphoma
New research indicates that re-treating diffuse large B-cell lymphoma patients with R-CHOP can lead to durable responses and improved outcomes, particularly for those with late relapses.